Dudediligence.

Maravai LifeSciences Holdings, Inc

MRVINASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$69.0MSep ’24$56.6MDec ’24$46.9MMar ’25$47.4MJun ’25$41.6MSep ’25$49.9MDec ’25$65.8MMar ’26$51.4MJun ’26
Net income, by quarter
−$97.1MSep ’24−$25.9MDec ’24−$29.9MMar ’25−$39.6MJun ’25−$25.6MSep ’25−$35.7MDec ’25−$3.7MMar ’26−$12.4MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$799.2M$883.0M$288.9M$259.2M$185.7M
Gross profit$658.7M$714.0M$140.2M$108.3M$34.0M
Operating income$554.6M$574.2M−$31.6M−$235.6M−$215.3M
Net income$182.0M$220.2M−$119.0M−$144.8M−$130.8M
Operating cash flow$368.6M$536.0M$126.2M$7.5M−$57.6M
Free cash flow$353.7M$518.9M$60.7M−$22.2M−$70.7M
Cash$551.3M$632.1M$575.0M$322.4M$216.9M
Debt$530.6M$527.4M$524.1M$295.9M$291.8M
Shares outstanding257.8M255.3M131.9M137.9M144.4M